Form 4: TransMedics Group Officer Anil Ranganath Reports Stock and Option Transactions

Sentiment:

SEC Form 4


Anil Ranganath, a Senior Vice President at TransMedics Group, reported the acquisition of restricted stock units and a stock option, along with stock acquired through the employee stock purchase plan.

Summary

  • Anil Ranganath, a Senior Vice President at TransMedics Group, filed a Form 4 detailing changes in beneficial ownership.
  • On February 24, 2025, Ranganath acquired 5,634 restricted stock units (RSUs), each representing a contingent right to receive one share of TransMedics Group common stock.
  • On the same date, Ranganath also acquired a stock option for 8,479 shares of common stock at an exercise price of $77.12, vesting monthly until February 24, 2029.
  • Additionally, Ranganath acquired 114 shares of common stock on December 31, 2024, through the company's Employee Stock Purchase Plan (ESPP) at a discounted price.
  • Following these transactions, Ranganath beneficially owns 14,641 shares of TransMedics Group common stock and 8,479 shares via stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

  • The acquisition of RSUs and stock options could align Ranganath's interests with those of the company and its shareholders.
  • Participation in the ESPP demonstrates Ranganath's investment in the company's future.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Comparison to Industry Standards

  • Stock option grants and RSU awards are common forms of compensation for executives in publicly traded companies, particularly in the technology and healthcare sectors.
  • The vesting schedule of the stock option (monthly until February 24, 2029) is a typical arrangement designed to incentivize long-term commitment.
  • Employee Stock Purchase Plans (ESPPs) are also a common benefit offered by many companies, allowing employees to purchase company stock at a discounted price.

Stakeholder Impact

  • The transactions reported may be of interest to shareholders as they provide insight into the actions of company insiders.

Key Dates

DateDescription
January 13, 2025Power of Attorney executed by Anil Ranganath.
December 31, 2024Acquisition of 114 shares through the ESPP.
February 24, 2025Acquisition of 5,634 RSUs and stock option for 8,479 shares.
February 24, 2029Full vesting date of the stock option.
February 24, 2035Expiration date of the stock option.
February 26, 2025Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.